Page 266 - Read Online

Gacad et al. Vessel Plus 2019;3:28 I http://dx.doi.org/10.20517/2574-1209.2019.011 Page 9 of 10

(ISAR-CABG): a randomised controlled superiority trial. Lancet 2011;378:1071-8.
41. Brilakis ES, Banerjee S, Burke MN. A new treatment strategy for saphenous vein graft lesions?: Letting it Go. J Am Coll Cardiol
2018;71:1983-5.
42. Gaudino M, Antoniades C, Benedetto U, Deb S, Di Franco A, et al. Mechanisms, consequences, and prevention of coronary graft
failure. Circulation 2017;136:1749-64.
43. Avgerinos DV, Charitakis K. Hybrid coronary revascularization: present and future. Hellenic J Cardiol 2015;56:193-6.
44. Davies MJ. The pathology of myocardial ischaemia. J Clin Pathol Suppl (R Coll Pathol) 1977;11:45-52.
45. Puskas JD, Halkos ME, DeRose JJ, Bagiella E, Miller MA, et al. Hybrid coronary revascularization for the treatment of multivessel
coronary artery disease: a multicenter observational study. J Am Coll Cardiol 2016;68:356-65.
46. Otsuka F, Yahagi K, Sakakura K, Virmani R. Why is the mammary artery so special and what protects it from atherosclerosis? Ann
Cardiothorac Surg 2013;2:519-26.
47. Zhang M, Guddeti RR, Matsuzawa Y, Sara JD, Kwon TG, et al. Left internal mammary artery versus coronary stents: impact on
downstream coronary stenoses and conduit patency. J Am Heart Assoc 2016;5.
48. Kitamura S. Physiological and metabolic effects of grafts in coronary artery bypass surgery. Circ J 2011;75:766-72.
49. ElBardissi AW, Aranki SF, Sheng S, O’Brien SM, Greenberg CC, et al. Trends in isolated coronary artery bypassgrafting: an analysis of
the Society of Thoracic Surgeons adult cardiac surgery database. J Thorac Cardiovasc Surg 2012;143:273-81.
50. Hlatky MA, Boothroyd DB, Reitz BA, Shilane DA, Baker LC, et al. Adoption and effectiveness of internal mammary artery grafting in
coronary artery bypass surgery among Medicare beneficiaries. J Am Coll Cardiol 2014;63:33-9.
51. Tabata M, Grab JD, Khalpey Z, Edwards FH, O’Brien SM, et al. Prevalence and variability of internal mammary artery graft use in
contemporary multivessel coronary artery bypass graft surgery: analysis of the Society of Thoracic Surgeons National Cardiac Database.
Circulation 2009;120:935-40.
52. Diegeler A, Thiele H, Falk V, Hambrecht R, Spyrantis N, et al. Comparison of stenting with minimally invasive bypass surgery for
stenosis of the left anterior descending coronary artery. N Engl J Med 2002;347:561-6.
53. Bhatt DL. CABG the clear choice for patients with diabetes and multivessel disease. Lancet 2018;391:913-4.
54. Cosgrove DM, Loop FD, Lytle BW, Gill CC, Golding LA, et al. Predictors of reoperation after myocardial revascularization. J Thorac
Cardiovasc Surg 1986;92:811-21.
55. Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, et al. Mortality after coronary artery bypass grafting versus percutaneous
coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet 2018;391:939-48.
56. Farooq V, Serruys PW, Zhang Y, Mack M, Ståhle E, et al. Short-term and long-term clinical impact of stent thrombosis and graft
occlusion in the SYNTAX trial at 5 years: synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. J
Am Coll Cardiol 2013;62:2360-9.
57. Cassese S, Piccolo R, Galasso G, De Rosa R, Piscione F. Twelve-month clinical outcomes of everolimus-eluting stent as compared
to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized
clinical trials. Int J Cardiol 2011;150:84-9.
58. Onuma Y, Miquel-Hebert K, Serruys PW, Investigators SI. Five-year long-term clinical follow-up of the XIENCE V everolimus-
eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trial. EuroIntervention
2013;8:1047-51.
59. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Heart disease and stroke statistics-2016 update: a report from the
American Heart Association. Circulation 2016;133:e38-360.
60. Pi Y, Roe MT, Holmes DN. Utilization, Characteristics, and In-Hospital Outcomes of Coronary Artery Bypass Grafting in Patients With
ST-Segment-Elevation Myocardial Infarction: Results From the National Cardiovascular Data Registry Acute Coronary Treatment and
Intervention Outcomes Network Registry-Get With The Guidelines. Circ Cardiovasc Qual Outcomes 2017;10.
61. Deeik RK, Schmitt TM, Ihrig TG, Sugimoto JT. Appropriate timing of elective coronary artery bypass graft surgery following acute
myocardial infarction. Am J Surg 1998;176:581-5.
62. Lee DC, Oz MC, Weinberg AD, Ting W. Appropriate timing of surgical intervention after transmural acute myocardial infarction. J
Thorac Cardiovasc Surg 2003;125:115-9; discussion 119.
63. Parikh SV, de Lemos JA, Jessen ME, Brilakis ES, Ohman EM, et al. Timing of in-hospital coronary artery bypass graft surgery for
non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-
GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines). JACC Cardiovasc Interv
2010;3:419-27.
64. Thomas MP, Bates ER. Update on primary PCI for patients with STEMI. Trends Cardiovasc Med 2017;27:95-102.
65. Chang M, Lee CW, Ahn JM, Cavalcante R, Sotomi Y, et al. Comparison of outcome of coronary artery bypass grafting versus drug-
eluting stent implantation for non-ST-elevation acute coronary syndrome. Am J Cardiol 2017;120:380-6.
66. Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, et al. Complete revascularisation versus treatment of the culprit lesion
only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label,
randomised controlled trial. Lancet 2015;386:665-71.
67. Zimarino M, Ricci F, Romanello M, Di Nicola M, Corazzini A, et al. Complete myocardial revascularization confers a larger clinical
benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: a meta-analysis
of randomized and observational studies. Catheter Cardiovasc Interv 2016;87:3-12.